A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP‐2 and Sm29 was able to induce protection against infection in mice

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Parasite immunology (Print)

• Publication date

  2014-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/pim.12118PMID 24749785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vaccination with Enzymatically Cleaved GPI-Anchored Proteins from Schistosoma mansoni Induces Protection against Challenge Infection

  2012cited by this paper
• Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2

  2012cited by this paper
• Computational Vaccinology: An Important Strategy to Discover New Potential S. mansoni Vaccine Candidates

  2011cited by this paper
• Schistosomiasis elimination: lessons from the past guide the future.

  2010cited by this paper
• Elimination of Neglected Diseases in Latin America and the Caribbean: A Mapping of Selected Diseases

  2010cited by this paper
• Construction, purification, and evaluation of multivalent DNA vaccine against Schistosoma japonicum

  2010cited by this paper
• A strategy to control transmission of Schistosoma japonicum in China.

  2009cited by this paper
• Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology

  2009cited by this paper
• Current Status of Vaccines for Schistosomiasis

  2008cited by this paper
• Trick or Treat: The Role of Vaccines in Integrated Schistosomiasis Control

  2008cited by this paper
• A century of schistosomiasis research.

  2008cited by this paper
• Recent advances in vaccine research against schistosomiasis in Brazil.

  2008cited by this paper
• Schistosoma mansoni Tegument Protein Sm29 Is Able to Induce a Th1-Type of Immune Response and Protection against Parasite Infection

  2008cited by this paper
• Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine.

  2008cited by this paper
• Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.

  2008cited by this paper
• Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii

  2007cited by this paper
• Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis

  2007cited by this paper
• Schistosome membrane proteins as vaccines.

  2007cited by this paper
• Prediction of linear B-cell epitopes using amino acid pair antigenicity scale

  2007cited by this paper
• Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine.

  2006cited by this paper
• Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies

  2006cited by this paper
• Schistosoma japonicum: The design and experimental evaluation of a multivalent DNA vaccine

  2006cited by this paper
• Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis

  2006cited by this paper
• Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk.

  2006cited by this paper
• Human schistosomiasis.

  2006cited by this paper
• Prospects for development of a transmission blocking vaccine against Schistosoma japonicum

  2005cited by this paper
• Immunity induced by the radiation‐attenuated schistosome vaccine

  2005cited by this paper
• IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-γ and TNF-α dependent pathway

  2004cited by this paper
• IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway.

  2004cited by this paper
• Focus: Schistosomiasis

  2004cited by this paper
• Isolation of cDNAs Encoding Secreted and Transmembrane Proteins from Schistosoma mansoni by a Signal Sequence Trap Method

  2003cited by this paper
• Human IgG1 and IgG3 recognition of Schistosoma mansoni 14kDa fatty acid-binding recombinant protein.

  2000cited by this paper
• The global status of schistosomiasis and its control.

  2000cited by this paper
• Schistosomiasis vaccine development: approaches and prospects.

  1995cited by this paper
• Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae.

  1992cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections

  1979cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Pre-clinical studies of Schistosoma mansoni vaccines: A scoping review

  2025cites this paper
• mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni

  2025cites this paper
• mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni

  2025cites this paper
• Evaluating the Immunoprotective and Diagnostic Potential of Schistosoma mansoni Epitopes from Sm050890 and Sm141290 Proteins Identified Through Reverse Vaccinology

  2025cites this paper
• Therapeutic and vaccinomic potential of moonlighting proteins for the discovery and design of drugs and vaccines against schistosomiasis.

  2024cites this paper
• A Recent Advance in the Diagnosis, Treatment, and Vaccine Development for Human Schistosomiasis

  2024cites this paper
• Construction and mouse antibody response evaluation of juvenile stage-specific chimeric protein from Fasciola gigantica.

  2024cites this paper
• A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments

  2023cites this paper
• Anti-schistosomal immunity to core xylose/fucose in N-glycans

  2023cites this paper
• Draft genome of the bluefin tuna blood fluke, Cardicola forsteri

  2022cites this paper
• Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects

  2022cites this paper
• Spatial expression pattern of serine proteases in the blood fluke Schistosoma mansoni determined by fluorescence RNA in situ hybridization

  2021cites this paper
• Evaluation of Immunogenicity and Efficacy of Fasciola hepatica Tetraspanin 2 (TSP2) Fused to E. coli Heat-Labile Enterotoxin B Subunit LTB Adjuvant Following Intranasal Vaccination of Cattle

  2021cites this paper
• Recent Advances and Methodological Considerations on Vaccine Candidates for Human Schistosomiasis

  2021influential citation
• Proteins as Targets in Anti-Schistosomal Drug Discovery and Vaccine Development

  2021cites this paper
• A comprehensive and critical overview of schistosomiasis vaccine candidates

  2021cites this paper
• Vaccination with chimeric protein induces protection in murine model against ascariasis.

  2020cites this paper
• Partial protection with a chimeric tetraspanin-leucine aminopeptidase subunit vaccine against Opisthorchis viverrini infection in hamsters.

  2020cites this paper
• Antibody responses to chimeric peptides derived from parasite antigens in mice and other animal species.

  2019cites this paper
• Moderate protection is induced by a chimeric protein composed of leucine aminopeptidase and cathepsin L1 against Fasciola hepatica challenge in sheep.

  2019cites this paper
• An Efficient Schistosoma japonicum Bivalent Membrane Protein Antigen DNA Vaccine Against Schistosomiasis in Mice

  2019cites this paper
• Protective Immune Responses Generated in a Murine Model Following Immunization with Recombinant Schistosoma japonicum Insulin Receptor

  2018cites this paper
• 1 Rethinking Schistosomiasis Vaccine Development : Synthetic Vesicles 1

  2018cites this paper
• A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against Schistosoma mansoni Reinfection in Mice

  2018cites this paper
• Schistosoma mansoni schistosomula antigens induce Th1/Pro‐inflammatory cytokine responses

  2018cites this paper
• The use of gold nanorods as a new vaccine platform against schistosomiasis

  2018cites this paper
• Extracellular vesicles from parasitic helminths and their potential utility as vaccines

  2018cites this paper
• S. mansoni Schistosomula Antigens Induce Th1/Proinflammatory Cytokine Responses

  2018cites this paper
• Biochemical and biophysical methodologies open the road for effective schistosomiasis therapy and vaccination.

  2017cites this paper
• Subtle Morbidity in Schistosomiasis

  2017cites this paper
• Suppression of mRNAs encoding CD63 family tetraspanins from the carcinogenic liver fluke Opisthorchis viverrini results in distinct tegument phenotypes

  2017cites this paper
• Rethinking Schistosomiasis Vaccine Development: Synthetic Vesicles.

  2017cites this paper
• Ultrastructural changes of Schistosoma mansoni worms associated with administration of its polyvalent vaccine

  2017cites this paper
• Schistosomiasis Vaccine Development: The Missing Link

  2017cites this paper
• Schistosoma mansoni Infection of Mice, Rats and Humans Elicits a Strong Antibody Response to a Limited Number of Reduction-Sensitive Epitopes on Five Major Tegumental Membrane Proteins

  2017cites this paper
• Schistosoma mansoni antigens alter activation markers and cytokine profile in lymphocytes of patients with asthma.

  2017cites this paper
• Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?

  2016cites this paper
• Development of a schistosomiasis vaccine

  2016cites this paper
• Schistosomiasis vaccines: where do we stand?

  2016cites this paper
• Host parasite communications—Messages from helminths for the immune system

  2016cites this paper
• Respuesta humoral IgM e IgG frente a antigenos de excreción-secreción de Schistosoma mansoni en murinos infectados y su relación con las citoquinas Il-10 y TNF-α

  2015cites this paper
• Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model

  2015cites this paper
• DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection

  2015cites this paper
• Eliminating Schistosomes through Vaccination: What are the Best Immune Weapons?

  2015cites this paper
• Exploring molecular variation in Schistosoma japonicum in China

  2015cites this paper
• Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.

  2014influential citation
• Liver fluke vaccines in ruminants: strategies, progress and future opportunities.

  2014cites this paper